OUR PRODUCTS

MOBILE APPS

GENERAL INFO

SLS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

SELLAS Life Sciences Group (SLS) Earnings Date & Reports

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SLS is expected to report earnings to rise 19.00% to -8 cents per share on November 12

SELLAS Life Sciences Group SLS Stock Earnings Reports

Q3'25

Est.

$-0.08

Q2'25

Beat

by $0.01

Q1'25

Beat

by $0.04

Q4'24

Beat

by $0.04

Q3'24

Beat

by $0.03

The last earnings report on August 12 showed earnings per share of -7 cents, beating the estimate of -7 cents. With 1.25M shares outstanding, the current market capitalization sits at 202.17M.

View a ticker or compare two or three

Compare

SLS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SLS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SLS showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

7 Times Square

Phone

+1 646 200-5278

Employees

Web

https://www.sellaslifesciences.com